Director, Medical Affairs (m/f/d)

Abbott – Heart Failure Division

Abbott’s Heart Failure business is expanding its Global Medical Affairs organization, and we are seeking an experienced Director, Global Medical Affairs to help shape the future of mechanical circulatory support and hemodynamic management worldwide.

This strategic leadership role reports directly to the Chief Medical Officer / Divisional Vice President, Global Medical Affairs and will be based in Europe.

Why This Role Matters

This is a high‑impact position at the forefront of advancing innovative therapies for patients living with heart failure. The Director will play a key role in guiding the clinical and scientific strategy across a rapidly evolving portfolio, partnering closely with Clinical Affairs, R&D, Market Access, Marketing, and Commercial teams.

The role requires a significant global presence (approx. 60% travel) to engage with investigators, clinical sites, and internal stakeholders.

This position will manage Clinical Research professionals to provide medical guidance for the business group, including support to maintain focus on product performance and safety, ISS, grants, and scientific activities. In addition, Director will work cross functionally to support the review, implementation and publication of clinical trial results. This role provides input to establish the range plans and goals for clinical science, and is responsible for the implementation and maintenance of the clinical research-related policies, processes and procedures related to their respective functional areas.

Director provides leadership and direction to product performance testing and evaluation, use clinical and medical experience and knowledge in the area of clinical research, and safety to direct risk management activities, and serves as an advisor to Clinical Affairs to support publications, abstracts and presentation of clinical research. Ensures critical input to establish and implement required product safety processes and procedures for new products and technologies as clinical studies are implemented, worldwide regulatory approvals are obtained and new products are commercialized.